Budget Amount *help |
¥3,700,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥600,000)
Fiscal Year 2009: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2008: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2007: ¥1,100,000 (Direct Cost: ¥1,100,000)
|
Research Abstract |
RET-transgenic mice, which develop malignant melanoma, are useful for finding biomarkers which express in the serum or urine correlated with tumor progression and/or metastasis. We found that chemokin (C-X-C motif) ligand, CXCL10 and CXCL16 are significantly increased in serum of RET-transgenic mice which has malignant tumor. Our findings suggest that these proteins can be candidates for new biomarkers of melanoma.
|